<DOC>
	<DOCNO>NCT01244659</DOCNO>
	<brief_summary>Comparison safety efficacy immunosuppressive regiment use tacrolimus EMS Prograf® post renal transplanted patient .</brief_summary>
	<brief_title>A Randomized Study Assess Safety Efficacy Tacrolimus v Prograf® Renal Transplantation Treatment</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>Age &gt; 18 year old Patient receive kidney live death donor Kidney donor young 65 year old PRA ≤ 30 % Negative pregnancy test woman Patient agreement practice birth control Patient fully inform give write informed consent HLA identical Patient multiorgan transplant recipient Any pathology past medical condition interfere protocol Allergy intolerance study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Kidney transplantation</keyword>
</DOC>